I'm wondering why existing ELISA tests for SARS-CoV-2 only target the immune system's antibody against the virus instead of the antigen - (S) spike glycoprotein? Then the assay could detect the virus before the immune system has found the appropriate antibody against the virus.

Will the spike glycoprotein still bind to an antibody that's fixed to a well while it is attached to the virus capsid? If this is not known for this particular virus, has it been done with other viruses?

More Nico Crudele's questions See All
Similar questions and discussions